Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2019 Financial Results on February 12, 2019
February 07, 2019 06:00 ET | Elite Pharmaceuticals, Inc.
Northvale, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
SunGen Pharma.jpg
SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA
December 11, 2018 07:30 ET | SunGen Pharma LLC
PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
SunGen Pharma.jpg
SunGen Pharma Receives US FDA Approval for Prednisone ANDA
December 10, 2018 12:28 ET | SunGen Pharma LLC
PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall®
December 10, 2018 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Receives FDA Approval for Hydrocodone and Acetaminophen Combo
November 20, 2018 11:05 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information
November 09, 2018 16:45 ET | Elite Pharmaceuticals, Inc.
Conference Call Scheduled for Monday, November 12th at 11:30 AM EST NORTHVALE, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2019 Financial Results on November 12, 2018
November 07, 2018 07:30 ET | Elite Pharmaceuticals, Inc.
Financials for Second Quarter Fiscal Year 2019 Ended September 30, 2018 will be released November 9, 2018 NORTHVALE, N.J, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Launches Generic Methadone Tablets
November 05, 2018 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
October 23, 2018 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Files ANDA for Codeine and Acetaminophen Combo
September 18, 2018 11:13 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...